Sanofi Hampered By Fitusiran Clinical Hold In Hemophilia
Reports Of Non-Fatal Thrombotic Events
The French major stressed to Scrip that patients enrolled in its fitusiran clinical trials often have other health issues and various co-morbidities, so it is too early to know if the adverse events are treatment-related.
